[go: up one dir, main page]

NO20034214D0 - Dermalt applikasjonssystem for aminolevulinsyrederivater - Google Patents

Dermalt applikasjonssystem for aminolevulinsyrederivater

Info

Publication number
NO20034214D0
NO20034214D0 NO20034214A NO20034214A NO20034214D0 NO 20034214 D0 NO20034214 D0 NO 20034214D0 NO 20034214 A NO20034214 A NO 20034214A NO 20034214 A NO20034214 A NO 20034214A NO 20034214 D0 NO20034214 D0 NO 20034214D0
Authority
NO
Norway
Prior art keywords
aminolevulinic acid
application system
acid derivatives
dermal application
dermal
Prior art date
Application number
NO20034214A
Other languages
English (en)
Other versions
NO333423B1 (no
NO20034214L (no
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Ulrich Kosciessa
Original Assignee
Photonamic Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh & Co Kg filed Critical Photonamic Gmbh & Co Kg
Publication of NO20034214D0 publication Critical patent/NO20034214D0/no
Publication of NO20034214L publication Critical patent/NO20034214L/no
Publication of NO333423B1 publication Critical patent/NO333423B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20034214A 2002-01-23 2003-09-22 Dermalt paforingssystem som er et selvklebende matrikssystem og fremgangsmate for fremstilling derav. NO333423B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10202487A DE10202487A1 (de) 2002-01-23 2002-01-23 Dermales Applikationssystem für Aminolävulinsäure-Derivate
PCT/EP2003/000406 WO2003061621A2 (de) 2002-01-23 2003-01-16 Dermales applikationssystem für aminolävulinsäure-derivate

Publications (3)

Publication Number Publication Date
NO20034214D0 true NO20034214D0 (no) 2003-09-22
NO20034214L NO20034214L (no) 2003-11-24
NO333423B1 NO333423B1 (no) 2013-06-03

Family

ID=7712859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034214A NO333423B1 (no) 2002-01-23 2003-09-22 Dermalt paforingssystem som er et selvklebende matrikssystem og fremgangsmate for fremstilling derav.

Country Status (13)

Country Link
US (1) US8465762B2 (no)
EP (1) EP1467706B1 (no)
JP (1) JP2005521654A (no)
AT (1) ATE356610T1 (no)
AU (1) AU2003206734B2 (no)
CY (1) CY1106577T1 (no)
DE (2) DE10202487A1 (no)
DK (1) DK1467706T3 (no)
ES (1) ES2281621T3 (no)
NO (1) NO333423B1 (no)
PT (1) PT1467706E (no)
SI (1) SI1467706T1 (no)
WO (1) WO2003061621A2 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
PL1877509T3 (pl) 2005-03-17 2012-03-30 Pharmafilm S R L Wodny układ polimerowy do wytwarzania matrycy kleju przylepcowego
JP5081121B2 (ja) * 2008-10-17 2012-11-21 株式会社ミルボン 育毛剤組成物
EP2590714B1 (en) * 2010-07-09 2017-03-08 Photocure ASA Devices containing dry compositions for use in photodynamic therapy
DE102011111865A1 (de) 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
US9600434B1 (en) 2011-12-30 2017-03-21 Bedrock Automation Platforms, Inc. Switch fabric having a serial communications interface and a parallel communications interface
US11314854B2 (en) 2011-12-30 2022-04-26 Bedrock Automation Platforms Inc. Image capture devices for a secure industrial control system
US9727511B2 (en) 2011-12-30 2017-08-08 Bedrock Automation Platforms Inc. Input/output module with multi-channel switching capability
US8868813B2 (en) 2011-12-30 2014-10-21 Bedrock Automation Platforms Inc. Communications control system with a serial communications interface and a parallel communications interface
US11967839B2 (en) 2011-12-30 2024-04-23 Analog Devices, Inc. Electromagnetic connector for an industrial control system
US9467297B2 (en) 2013-08-06 2016-10-11 Bedrock Automation Platforms Inc. Industrial control system redundant communications/control modules authentication
US12061685B2 (en) 2011-12-30 2024-08-13 Analog Devices, Inc. Image capture devices for a secure industrial control system
US10834094B2 (en) 2013-08-06 2020-11-10 Bedrock Automation Platforms Inc. Operator action authentication in an industrial control system
US11144630B2 (en) 2011-12-30 2021-10-12 Bedrock Automation Platforms Inc. Image capture devices for a secure industrial control system
US8971072B2 (en) 2011-12-30 2015-03-03 Bedrock Automation Platforms Inc. Electromagnetic connector for an industrial control system
US8862802B2 (en) 2011-12-30 2014-10-14 Bedrock Automation Platforms Inc. Switch fabric having a serial communications interface and a parallel communications interface
US10834820B2 (en) 2013-08-06 2020-11-10 Bedrock Automation Platforms Inc. Industrial control system cable
US9437967B2 (en) 2011-12-30 2016-09-06 Bedrock Automation Platforms, Inc. Electromagnetic connector for an industrial control system
US9191203B2 (en) 2013-08-06 2015-11-17 Bedrock Automation Platforms Inc. Secure industrial control system
RU2635563C2 (ru) 2012-08-03 2017-11-14 ФотоКьюэр АСА Соединения
US10613567B2 (en) 2013-08-06 2020-04-07 Bedrock Automation Platforms Inc. Secure power supply for an industrial control system
CN105281061A (zh) 2014-07-07 2016-01-27 基岩自动化平台公司 工业控制系统电缆
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
KR200483745Y1 (ko) 2017-02-16 2017-06-19 김태완 자동차 매너 클락션 장치
EP3606410B1 (en) 2017-04-04 2022-11-02 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US12039726B2 (en) 2019-05-20 2024-07-16 Aranz Healthcare Limited Automated or partially automated anatomical surface assessment methods, devices and systems

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (no) 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4320871C2 (de) 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
AU3176695A (en) 1994-09-20 1996-04-04 Johnson & Johnson Medical, Inc. Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
JPH11514986A (ja) * 1995-09-21 1999-12-21 ノバルティス アクチエンゲゼルシャフト 光力学的療法におけるナノ粒子
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (de) 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
EP1231877A4 (en) * 1999-11-04 2009-03-18 Xel Herbaceuticals TRANSDERMALE ADMINISTRATION OF HUPERZIN
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
EP1453789A2 (en) * 2001-11-08 2004-09-08 Elan Pharmaceuticals, Inc. N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives

Also Published As

Publication number Publication date
ATE356610T1 (de) 2007-04-15
DE10202487A1 (de) 2003-07-31
EP1467706A2 (de) 2004-10-20
US8465762B2 (en) 2013-06-18
WO2003061621A3 (de) 2003-12-31
NO333423B1 (no) 2013-06-03
SI1467706T1 (sl) 2007-06-30
JP2005521654A (ja) 2005-07-21
AU2003206734B2 (en) 2007-09-06
DK1467706T3 (da) 2007-07-09
PT1467706E (pt) 2007-03-30
EP1467706B1 (de) 2007-03-14
DE50306796D1 (de) 2007-04-26
ES2281621T3 (es) 2007-10-01
US20060018956A1 (en) 2006-01-26
NO20034214L (no) 2003-11-24
CY1106577T1 (el) 2012-01-25
WO2003061621A2 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
DK1467706T3 (da) Dermalt applikationssystem for aminolevulinsyre-derivater
ATE464041T1 (de) Zusammensetzung zur hautaufhellung
PT1258476E (pt) Derivados de alfa-amino-acidos, processo para sua preparacao assim como a sua utilizacao como inibidores de dipeptidil-peptidase iv (dpp iv).
AU2003206734A1 (en) Dermal application system for aminolevulinic acid-derivatives
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
UY26841A1 (es) Sales estables de ácido o-acetilsalicílico con aminoácidos básicos
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
BR0308967A (pt) Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
NO20043353L (no) Antistoff-inneholdende opplosningsfarmasoytika
BRPI0413973A (pt) compostos
BRPI0414598A (pt) indóis substituìdos
CY1105994T1 (el) Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων
AU2008255733A8 (en) Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
ECSP045221A (es) Sales de valsartan
NO20030182D0 (no) Dermalt påföringssystem for aminolevulinsyre
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
AU4249700A (en) Hydroxamic acid derivative
ECSP045215A (es) Metabolitos del ácido (3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acético
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ATE242763T1 (de) Methoximinophenylessigsäureamide
NO20053208D0 (no) Metode for reduktiv dehalogenering.

Legal Events

Date Code Title Description
MK1K Patent expired